Yeztugo PrEP Works Well for Young People
|
Lenacapavir, from Gilead Sciences, is an antiretroviral
drug that blocks HIV replication. It is not a vaccine that trains the immune
system to ... |
amfAR Awards Boost Aspiring HIV Researchers
While antiretroviral therapy stops HIV from replicating, it cannot eradicate the hidden reservoir of dormant virus, the main barrier to a cure. View article...